CircHECTD1 Regulates Cell Proliferation and Migration by the miR-320-5p/SLC2A1 Axis in Glioblastoma Multiform

Area of Science:

• Oncology
• Molecular Biology
• Genetics

Background:

• Glioblastoma multiforme (GBM) is a highly aggressive primary brain cancer with limited treatment options.
• Circular RNAs (circRNAs) are emerging as key regulators in tumor progression and potential therapeutic targets.
• Understanding the role of specific circRNAs in GBM is crucial for developing novel strategies.

Purpose of the Study:

• To investigate the role of circHECTD1 in the progression of glioblastoma.
• To elucidate the molecular mechanism involving circHECTD1, miR-320-5p, and SLC2A1 in GBM.
• To evaluate circHECTD1 as a potential therapeutic target for GBM.

Main Methods:

• Quantitative real-time PCR (qRT-PCR) and Western blot to detect RNA and protein expression.
• Cellular assays including flow cytometry, EdU, colony formation, Transwell, and wound-healing assays to assess proliferation and migration.
• Luciferase reporter assays and in vivo xenograft experiments to confirm interactions and evaluate tumor growth.

Main Results:

• circHECTD1 expression significantly promoted GBM cell proliferation and migration.
• circHECTD1 functions as a competing endogenous RNA (ceRNA) by sponging miR-320-5p.
• miR-320-5p directly targets solute carrier family 2 member 1 (SLC2A1), and circHECTD1 upregulates SLC2A1 expression.

Conclusions:

• The circHECTD1-miR-320-5p-SLC2A1 axis plays a critical role in promoting GBM progression.
• circHECTD1 enhances GBM cell proliferation and migration through this regulatory pathway.
• circHECTD1 represents a promising therapeutic target for glioblastoma treatment.